BioAge Labs (BIOA) Change in Cash (2023 - 2026)

BioAge Labs (BIOA) has 4 years of Change in Cash data on file, last reported at $52.9 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Cash rose 154.6% year-over-year to $52.9 million; the trailing twelve-month figure through Mar 2026 stood at -$15.7 million (down 119.59% YoY), and the FY2025 full-year result was -$165.5 million, down 150.23% from the prior year.
• Change in Cash advanced to $52.9 million in Q1 2026, from -$26.7 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $175.4 million in Q3 2024 to a low of -$96.9 million in Q1 2025.
• A 4-year average of $20.7 million and a median of -$7.2 million in 2023 frame the typical range for Change in Cash.
• Across the five-year window, Change in Cash soared 307.53% in 2024 and slumped 234.26% in 2025, its largest moves.
• Tracing BIOA's Change in Cash over 4 years: stood at -$9.6 million in 2023, then soared by 307.53% to $19.9 million in 2024, then tumbled by 234.26% to -$26.7 million in 2025, then jumped by 298.2% to $52.9 million in 2026.
• Business Quant data shows BIOA's Change in Cash at $52.9 million in Q1 2026, -$26.7 million in Q4 2025, and -$4.8 million in Q3 2025.